TP53 and cancer: The DepMap portal data explorer tool was used to assess the association of gene effect scores for S5A and ADRM1 with p53 mutational status in Wellcome Sanger Institute whole‐genome CRISPR cancer cell line screens (Project Score) [54, 59, 60, 63, 81].